Providing executive-level business, marketing and operational strategy expertise to emerging health and medical technology organizations.

In combination with the acquisition of Corventis by Medtronic, I assumed full operations leadership responsibility for a portfolio of 24x7 cardiac diagnostic services provided to Electrophysiologists and Cardiologists as well as biopharmaceutical firms across the globe.•Scaled the Medtronic Monitoring cardiac monitoring services organization from 15 to 100 employees across multiple sites to enable service delivery at an annual run-rate of over 20,000 patients•Established a second Medtronic Monitoring Center site in South San Francisco, CA and obtained multiple Medicare Independent Diagnostic Testing Facility (IDTF) certifications to support claims submission •Led the definition of service requirements, launched new services and successfully transitioned service operations across monitoring center sites in both the United States and India•Created and implemented a suite of key performance and quality metrics to guide operations and resourcing•Identified and introduced organizational, procedural and system enhancement initiatives that drove continuous improvement in service consistency, efficiency, quality and customer satisfaction (Net Promoter Score)•Recruited and managed a team of Supervising Physicians to support Medicare certification, optimize clinical policies and deliver an electrophysiology educational curriculum for monitoring center employees •Selected for the Medtronic IGNITE Leadership Development Program and nominated for the Medtronic Star of Excellence, the Medtronic Compass and the Medtronic Global Preclinical Research Excellence awards

Leading up to the acquisition of Corventis by Medtronic, I assumed expanded operational leadership responsibilities for our patient monitoring clinical service operations serving US patients from the Pennsylvania-based Independent Diagnostic Testing Facility (IDTF)

With the continued growth and transformation of Corventis as an organization, marketing objectives and responsibilities for my role shifted from product strategy and product management (upstream marketing) towards building a stronger presence and global brand for Corventis, traditional product marketing, launch management and evidence generation across the US and India. •Updated the Corventis corporate messaging framework and drove the redesign and launch of the Corventis corporate website•Managed launches of NUVANT MCT services and service enhancements in the US, India and other geographies, including product/service positioning and messaging as well as collateral development and sales training•Partnered with key opinion leaders to quantify the benefits of NUVANT MCT and secured acceptance of a corresponding scientific abstract with the Heart Rhythm Society •Secured company awards including the World Economic Forum Tech Pioneer Award (2010), Life Science Alley New Technology Showcase Award (2012) and Minnesota High Tech Association Tekne Award (2013)

Recruited at company inception/incubation as the marketing and business lead to accelerate the development and commercialization of a disruptive wearable, wireless arrhythmia and heart failure diagnostic. Funded by Kleiner Perkins, Mohr Davidow Ventures and PTV Ventures•Led product managers to create quantitative and qualitative market, clinical and customer needs assessments•Defined service, hardware and software/UI requirements for two wearable, wireless cardiac diagnostic solutions in five geographies, as well as requirements for multiple adjacent pipeline solutions •Established the product planning process and drove prioritization of new features and enhancements across product lines by sourcing internal stakeholder and customer feedback as well as quantifying financial benefit•Launched market preference tests to capture customer feedback for product planning and prioritization •Created market, revenue, product cost and valuation models for company strategic decisions, financing activities and business development transactions•Developed investor presentations, led product demonstrations and participated in fundraising activities•Partnered with key consultants to define the reimbursement strategy for Corventis service solutions •Managed external PR firms and consultants, wrote press releases and secured media coverage for Corventis in local and national outlets such as the Wall Street Journal, Inc. Magazine, Scientific American, Fast Company, Startup, MIT Technology Review, KTVU Channel 2 News and ABC Channel 7 News

After the acquisition of Guidant's Vascular Intervention (VI) group by Abbott in 2006, I assumed expanded responsibilities for investments supporting the Carotid/Neuro Division of the newly formed Abbott Vascular and joined Abbott's Corporate Licensing and Acquisitions team•Led a cross-functional team to critically evaluate competing internal product initiatives in the combined Guidant/Abbott and to drive consensus on the necessity of an alternative time-sensitive external acquisition target•Reassessed and renegotiated historical agreements to address the needs and priorities of the newly combined Guidant Vascular Intervention and Abbott Vascular businesses

Business Development lead in Guidant's West Coast Business Development / Compass Group responsible for opportunity assessment, technology assessment, valuation, contract negotiation and due diligence for transactions and investments primarily supporting the Vascular Intervention (VI) division •Secured internal approval and led all aspects of technical, financial and operational due diligence as well as contract negotiation for a multi-million dollar combination product spin-off and licensing transaction •Partnered with Guidant VI Marketing to identify key performance criteria for core interventional products and managed performance evaluations of external product technologies with internal stakeholders and physicians•Negotiated material transfer and research agreements to establish technology development partnerships between Guidant VI R&D and outside entities

Analyzed market dynamics, technological trends and internal capabilities to identify strategic investment opportunities for the New Ventures team within Guidant’s Vascular Intervention (VI) business unit•Member of a cross-functional team that defined the long-term strategy for Guidant Vascular Intervention (VI)•Independently investigated and recommended an investment in an emerging therapy to senior management